Two manufacturers of the widely used abortion pill mifepristone have urgently appealed to the Supreme Court, seeking to block an appellate court ruling that, just a day prior, halted mail-order access to the medication.
This development marks the most significant shift in US abortion policy since the overturning of Roe v. Wade.